AIC
RANI icon

AWM Investment Company’s Rani Therapeutics RANI Stock Holding History

AWM Investment Company’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.7M Buy
7,500,000
+1,000,000
+15% +$887K 0.49% 56
2026
Q1 		$4.78M Hold
6,500,000
– – 0.53% 49
2025
Q4 		$8.78M Buy
+6,500,000
New +$9.81M 0.85% 36

Other funds holding RANI

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

AWM Investment Company's RANI Position: Q2 2026 in Review

AWM Investment Company increased its Rani Therapeutics (RANI) stake by 15% in Q2 2026, buying an estimated $887K and bringing the position to 7,500,000 shares worth $5.7M. The position accounts for 0.49% of the portfolio, ranked #56.

AWM Investment Company first reported a position in RANI in Q4 2025 and has held it in 3 quarters since. The position peaked at $8.78M in Q4 2025. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • AWM Investment Company held 7,500,000 shares of Rani Therapeutics worth $5.7M as of Q2 2026.
  • AWM Investment Company bought 1,000,000 Rani Therapeutics shares in Q2 2026, an estimated $887K.
  • Rani Therapeutics made up 0.49% of AWM Investment Company's portfolio in Q2 2026, its #56 holding.
  • AWM Investment Company first reported a position in Rani Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • AWM Investment Company's Rani Therapeutics position peaked at $8.78M in Q4 2025.
  • 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.